Assay Validation and Diagnostic Applications of Major Acute-phase Protein Testing in Companion Animals

Clinics in Laboratory Medicine

Volumn 31, Issue 1, 2011, Pages 51-70

  Kjelgaard Hansen, Mads ^a   Jacobsen, Stine ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acute phase proteins; Assay validation; C reactive protein; Serum amyloid A; Veterinary clinical pathology

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HAPTOGLOBIN; OROSOMUCOID; SERUM AMYLOID A;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SPECIES DIFFERENCE; VALIDATION PROCESS; VETERINARY MEDICINE;

ACUTE-PHASE PROTEINS; ANIMAL DISEASES; ANIMALS; BLOOD CHEMICAL ANALYSIS; CATS; CATTLE; DOGS; HORSES; INFLAMMATION; PETS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY; SWINE; VETERINARY MEDICINE;

EID: 79551475095     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.10.002     Document Type: Review

References (125)

1. Esposito S., Tremolati E., Begliatti E., et al. Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein. Clin Chem Lab Med 2005, 43(4):438-440.
2. Zecca E., Barone G., Corsello M., et al. Reliability of two different bedside assays for C-reactive protein in newborn infants. Clin Chem Lab Med 2009, 47(9):1081-1084.
3. Jacobsen S., Kjelgaard-Hansen M. Evaluation of a commercially available apparatus for measuring the acute phase protein serum amyloid A in horses. Vet Rec 2008, 163:327-330.
4. Kjelgaard-Hansen M. Clinical applicability of a point-of-care patient-side canine-specific commercially available quantitative assay for determination of C-reactive protein. Vet Clin Pathol 2009, 38(s1):E22. [abstract].
5. Onishi T., Inokuma H., Ohno K., et al. C-reactive protein concentrations in normal and diseased dogs - measured by laser nephelometric immunoassay. Nippon Juishikai Zasshi 2000, 53(9):595-601. [in Japanese].
6. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 1982, 38:939-948.
7. Jacobsen S., Jensen J.C., Frei S., et al. Using serum amyloid A and other acute phase reactants to monitor the inflammatory response after castration in horses - a field study. Eq Vet J 2005, 37(6):552-556.
8. Jacobsen S., Nielsen J.V., Kjelgaard-Hansen M., et al. Acute phase response to surgery of varying intensity in horses: a preliminary study. Vet Surg 2009, 38:762-769.
9. Hobo S., Niwa H., Anzai T. Evaluation of serum amyloid A and surfactant protein D in sera for identification of the clinical condition in horses with bacterial pneumonia. J Vet Med Sci 2007, 69(8):827-830.
10. Gabay C., Kushner I. Acute-phase proteins and other systemic response to inflammation. N Engl J Med 1999, 340(6):448-454.
11. McDonald T.L., Larson M.A., Mack D.R., et al. Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A 3 (M-SAA3) into colostrum. Vet Immunol Immunopathol 2001, 83:203-211.
12. Kumon Y., Suehiro T., Hashimoto K., et al. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J Rheumatol 1999, 26:785-790.
13. Zerega B., Pagano A., Pianezzi A., et al. Expression of serum amyloid A in chondrocytes and myoblasts differentiation and inflammation: possible role in cholesterol homeostasis. Matrix Biol 2004, 23:35-46.
14. Ramage L., Proudfoot L., Guy K. Expression of C-reactive protein in human lung epithelial cells and upregulation by cytokines and carbon particles. Inhal Toxicol 2004, 16(9):607-613.
15. Vreugdenhil A.C., Dentener M.A., Snoek A.M., et al. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol 1999, 163:2792-2798.
16. Benditt E.P., Meek R.L. Expression of the third member of the serum amyloid A gene family in mouse adipocytes. J Exp Med 1989, 169:1841-1846.
17. Christoffersen M., Baagoe C.D., Jacobsen S., et al. Evaluation of the systemic acute phase response and endometrial gene expression of serum amyloid A and pro- and anti-inflammatory cytokines in mares with experimentally induced endometritis. Vet Immunol Immunopathol 2010, 138(1-2):95-105.
18. 3 is a high density lipoprotein and is secreted by macrophages. Proc Natl Acad Sci U S A 1992, 89:7949-7952.
19. Urieli-Shoval S., Meek R.L., Hanson R.H., et al. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 1994, 145(3):650-660.
20. Jabs W.J., Lögering B.A., Gerke P., et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 2003, 33(1):152-161.
21. Toussaint M.J., van Ederen A.M., Gruys E. Implication of clinical pathology in assessment of animal health and in animal production and meat inspection. Comp Haematol Int 1995, 5:149-157.
22. Gånheim C., Alenius S., Persson-Waller K. Acute phase proteins as indicators of calf herd health. Vet J 2007, 173(3):645-651.
23. Petersen H.H., Ersbøll A.K., Jensen C.S., et al. Serum haptoglobin concentration in Danish slaughter pigs of different health status. Prev Vet Med 2002, 54:325-335.
24. Akerstedt M., Waller K.P., Sternesjö A. Haptoglobin and serum amyloid A in bulk tank milk in relation to raw milk quality. J Dairy Res 2009, 76(4):483-489.
25. Petersen H.H., Nielsen J.P., Heegaard P.M. Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res 2004, 35:163-187.
26. Chamanza R., van Veen L., Tivapasi M.T., et al. Acute phase proteins in the domestic fowl. Worlds Poult Sci J 1999, 55:61-71.
27. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999, 265:501-523.
28. Jacobsen S., Kjelgaard-Hansen M., Petersen H.H., et al. Evaluation of a commercially available human serum amyloid A (SAA) turbidometric immunoassay for determination of equine SAA concentrations. Vet J 2006, 172:315-319.
29. Kjelgaard-Hansen M., Jensen A.L., Kristensen A.T. Evaluation of a commercially available human C-reactive protein (CRP) turbidometric immunoassay for determination of canine serum CRP concentration. Vet Clin Pathol 2003, 32(2):81-87.
30. Jacobsen S., Niewold T.A., Kornalijnslijper E., et al. Kinetics of local and systemic isoforms of serum amyloid A in bovine mastitic milk. Vet Immunol Immunopathol 2005, 104(1-2):21-31.
31. Jacobsen S., Halling-Thomsen M., Nanni S. Concentrations of serum amyloid A in serum and synovial fluid from healthy horses and horses with joint disease. Am J Vet Res 2006, 67(10):1738-1742.
32. Kjelgaard-Hansen M., Christensen M.B., Lee M.H., et al. Serum amyloid A isoforms in serum and synovial fluid from spontaneously diseased dogs with joint diseases or other conditions. Vet Immunol Immunopathol 2007, 117(3-4):296-301.
33. Jacobsen S., Niewold T.A., Halling-Thomsen M., et al. Serum amyloid A isoforms in serum and synovial fluid in horses with lipopolysaccharide-induced arthritis. Vet Immunol Immunopathol 2005, 110(3-4):325-330.
34. Kluve-Beckerman B., Drumm M.L., Benson M.D. Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol 1991, 10(9):651-661.
35. Riley R.F., Coleman M.K. Isolation of C-reactive proteins of man monkey, rabbit and dog by affinity chromatography on phosphorylated cellulose. Clin Chim Acta 1970, 30:483-496.
36. Riley R.F., Zontine W. Further observations on the properties of dog C-reactive protein and the C-reactive protein response in the dog. J Lab Clin Med 1972, 80(5):698-703.
37. Caspi D., Baltz M.L., Snel F., et al. Isolation and characterization of C-reactive protein from the dog. Immunology 1984, 53(2):307-313.
38. Conner J.G., Eckersall P.D., Ferguson J., et al. Acute phase response in the dog following surgical trauma. Res Vet Sci 1988, 45(1):107-110.
39. Yamamoto S., Tagata K., Nagahata H., et al. Isolation of canine C-reactive protein and characterization of its properties. Vet Immunol Immunopathol 1992, 30(4):329-339.
40. Eckersall P.D. Acute phase proteins: from research laboratory to clinic. Vet Clin Pathol 2010, 39(1):1-2.
41. Yamamoto M., Miyaji S., Abe N., et al. Canine C-reactive protein (CRP) does not share common antigenicity with human CRP. Vet Res Commun 1993, 17(4):258-266.
42. Yamamoto S., Tagata K., Otabbe K., et al. Serum levels of C-reactive protein in dogs and simple techniques for its measurement. Nippon Juishikai Zasshi 1993, 46(10):870-873.
43. Concannon P.W., Gimpel T., Newton L., et al. Postimplantation increase in plasma fibrinogen concentration with increase in relaxin concentration in pregnant dogs. Am J Vet Res 1996, 57(9):1382-1385.
44. Klenner S., Bauer N., Moritz A. Evaluation of three automated human immunoturbidimetric assays for the detection of C-reactive protein in dogs. J Vet Diagn Invest 2010, 22:544-552.
45. Kjelgaard-Hansen M. Comments on measurement of C-reactive protein in dogs [letter]. Vet Clin Pathol 2010, 39:402-403.
46. Kjelgaard-Hansen M., Jensen A.L., Kristensen A.T. Internal quality control of a turbidimetric immunoassay for canine serum C-reactive protein based on pooled patient samples. Vet Clin Pathol 2004, 33(3):139-144.
47. Nakamura M., Takahashi M., Ohno K., et al. C-reactive protein concentration in dogs with various diseases. J Vet Med Sci 2008, 70(2):127-131.
48. Hansen A.E., Schaap M.K., Kjelgaard-Hansen M. Evaluation of a commercially available human serum amyloid A (SAA) turbidimetric immunoassay for determination of feline SAA concentration. Vet Res Commun 2006, 30(8):863-872.
49. Woo P., Edbrooke M., Betts J., et al. Serum amyloid A gene regulation. Acute phase proteins. Molecular biology, biochemistry and clinical application 1993, 397-408. CRC Press, Boca Raton (FL). 1st edition. A. Mackiewicz, I. Kushner, H. Baumann (Eds.).
50. Ceron J.J., Martinez-Subiela S., Ohno K., et al. A seven-point plan for acute phase protein interpretation in companion animals. Vet J 2008, 177(1):6-7.
51. Tamamoto T., Ohno K., Ohmi A., et al. Verification of measurement of the feline serum amyloid A (SAA) concentration by human SAA turbidimetric immunoassay and its clinical application. J Vet Med Sci 2008, 70(11):1247-1252.
52. Evidence-based Medicine Working Group Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 1992, 268:2420-2425.
53. Aragon C.L., Budsberg S.C. Applications of evidence-based medicine: cranial cruciate ligament injury repair in the dog. Vet Surg 2005, 34(2):93-98.
54. Martensen R.L. The effect of medical conservatism on the acceptance of important medical discoveries. JAMA 1996, 276(24):1933.
55. Knottnerus J.A., Dinant G.J. Medicine based evidence, a prerequisite for evidence based medicine. BMJ 1997, 315(7116):1109-1110.
56. Zweig M.H., Robertson E.A. Why we need better test evaluations. Clin Chem 1982, 28(6):1272-1276.
57. Fraser C.G. Biological variation: from principles to practice 2001, AACC Press, Washington, DC, p. 1-151.
58. Jensen A.L., Kjelgaard-Hansen M. Diagnostic test validation. Schalm's veterinary hematology 2010, 1027-1033. Blackwell, Ames (IA). 6th edition. D.J. Weiss, K.J. Wardrop (Eds.).
59. Jensen A.L., Kjelgaard-Hansen M. Method comparison in the clinical laboratory. Vet Clin Pathol 2006, 35(3):276-286.
60. Fraser C.G., Petersen P.H. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 1999, 45(3):321-323.
61. Kenny D., Fraser C.G., Petersen P.H., et al. Consensus agreement. Scand J Clin Lab Invest 1999, 59:585.
62. Kjelgaard-Hansen M., Mikkelsen L.F., Kristensen A.T., et al. Study on biological variability of five acute phase reactants in dogs. Comp Clin Path 2003, 12(2):69-74.
63. Kjelgaard-Hansen M., Jensen A.L. Subjectivity in defining quality specifications for quality control and test validation. Vet Clin Pathol 2010, 39(2):134-135.
64. McGrotty Y.L., Knottenbelt C.M., Ramsey I.K., et al. Evaluation of a rapid assay for canine C-reactive protein. Vet Rec 2004, 154(6):175-176.
65. Kjelgaard-Hansen M., Stadler M., Jensen A.L. Canine serum C-reactive protein detected by means of a near-patient test for human C-reactive protein. J Small Anim Pract 2008, 49(6):282-286.
66. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for reporting of diagnostic accuracy. Clin Chem 2003, 49(1):1-6.
67. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003, 49(1):7-18.
68. Christopher M.M. Improving the quality of reporting of studies of diagnostic accuracy: let's STARD now. Vet Clin Pathol 2007, 36(1):6.
69. Wiinberg B., Jensen A.L., Johansson P.I., et al. Development of a model based scoring system for diagnosis of canine disseminated intravascular coagulation with independent assessment of sensitivity and specificity. Vet J 2010, 185(3):292-298.
70. Smidt N., Overbeke J., de Vet H., et al. Endorsement of the STARD Statement by biomedical journals: survey of instructions for authors. Clin Chem 2007, 63(11):1983-1985.
71. Uzzan B., Cohen R., Nicolas P., et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34(7):1996-2003.
72. He L.P., Tang X.Y., Ling W.H., et al. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart 2010, 96(5):339-346.
73. Jergens A.E., Schreiner C.A., Frank D.E., et al. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003, 17(3):291-297.
74. Ceron J.J., Eckersall P.D., Martynez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 2005, 34(2):85-99.
75. Murata H., Shimada N., Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J 2004, 168(1):28-40.
76. Jacobsen S., Andersen P.H. The acute phase protein serum amyloid A (SAA) as a marker of inflammation in horses. Eq Vet Edu 2007, 19(1):38-46.
77. Paltrinieri S. The feline acute phase reaction. Vet J 2008, 177:26-35.
78. Pepys M.B., Baltz M.L., Tennent G.A. Serum amyloid A (SAA) in horses: objective measurement of the acute phase response. Eq Vet J 1989, 21(2):106-109.
79. Lindegaard C., Bech-Gleerup K.C., Thomsen M.H., et al. Anti-inflammatory effect of intra-articular morphine in a model of induced equine arthritis. Am J Vet Res 2010, 71(1):69-75.
80. Higgins M.A., Berridge B.R., Mills B.J., et al. Gene expression analysis of the acute phase response using a canine microarray. Toxicol Sci 2003, 74(2):470-484.
81. Kajikawa T., Furuta A., Onishi T., et al. Changes in concentrations of serum amyloid A protein, alpha 1-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery. Vet Immunol Immunopathol 1999, 68(1):91-98.
82. Chavatte PM, Pepys MB, Roberts B, et al. Measurement of serum amyloid A protein (SAA) as an aid to differential diagnosis of infection in newborn foals. In: Plowright W, Rossdale PD, Wade JF, editors. Proceedings of the 6th International Conference on Infectious Diseases. Newmarket (UK): R&W Publications; 1991. p. 33-8.
83. Hultén C., Demmers S. Serum amyloid A (SAA) as an aid in the management of infectious disease in the foal: comparison with total leukocyte count, neutrofil count and fibrinogen. Eq Vet J 2002, 34(7):693-698.
84. Stoneham S.J., Palmer L., Cash R., et al. Measurement of serum amyloid A in the neonatal foal using a latex agglutination immunoturbidometric assay: determination of the normal range, variation with age and response to disease. Eq Vet J 2001, 33(6):599-603.
85. Gardner R.B., Nydam D.V., Luna J.A., et al. Serum opsonization capacity, phagocytosis, and oxidative burst activity in neonatal foals in the intensive care unit. J Vet Intern Med 2007, 21:797-805.
86. Cohen N.D., Chaffin M.K., Vandenplas M.L., et al. Study of serum amyloid A concentrations as a means of achieving early diagnosis of Rhodococcus equi pneumonia. Eq Vet J 2005, 37(3):212-216.
87. Vandenplas M.L., Moore J.N., Barton M.H., et al. Concentrations of serum amyloid A and lipopolysaccharide-binding protein in horses with colic. Am J Vet Res 2005, 66(9):1509-1516.
88. Mansfield C.S., James F.E., Robertson I.D. Development of a clinical severity index for dogs with acute pancreatitis. J Am Vet Med Assoc 2008, 233(6):936-944.
89. Jergens A.E. Clinical assessment of disease activity for canine inflammatory bowel disease. J Am Anim Hosp Assoc 2004, 40(6):437-445.
90. Bathen-Noethen A., Carlson R., Menzel D., et al. Concentrations of acute-phase proteins in dogs with steroid responsive meningitis-arteritis. J Vet Intern Med 2008, 22(5):1149-1156.
91. Lowrie M., Penderis J., McLaughlin M., et al. Steroid responsive meningitis-arteritis: a prospective study of potential disease markers, prednisolone treatment, and long-term outcome in 20 dogs (2006-2008). J Vet Intern Med 2009, 23(4):862-870.
92. Sasaki K., Ma Z., Khatlani T.S., et al. Evaluation of feline serum amyloid A (SAA) as an inflammatory marker. J Vet Med Sci 2003, 65(4):545-548.
93. Paltrinieri S., Giordano A., Tranquillo V., et al. Critical assessment of the diagnostic value of feline alpha1-acid glycoprotein for feline infectious peritonitis using the likelihood ratios approach. J Vet Diagn Invest 2007, 19(3):266-272.
94. Busk P., Jacobsen S., Martinussen T. Administration of perioperative penicillin reduces postoperative serum amyloid A response in horses being castrated standing. Vet Surg 2010, 39:628-643.
95. Amar D., Zhang H., Park B., et al. Inflammation and outcome after general thoracic surgery. Eur J Cardiothorac Surg 2008, 32:431-434.
96. Hashimoto K., Ikeda Y., Korenaga D., et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005, 103:1856-1864.
97. Shiu Y.C., Lin J.K., Huang C.J., et al. Is C-reactive protein a prognostic factor of colorectal cancer?. Dis Colon Rectum 2008, 51:443-449.
98. Richard E.A., Fortier G.D., Pitel P.-H., et al. Sub-clinical diseases affecting performance in Standardbred trotters: Diagnostic methods and predictive parameters. Vet J 2010, 184:282-289.
99. Griebsch C., Arndt G., Raila J., et al. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia. Vet Clin Pathol 2009, 38(4):421-425.
100. Mitchell K.D., Kruth S.A., Wood R.D., et al. Serum acute phase protein concentrations in dogs with autoimmune hemolytic anemia. J Vet Intern Med 2009, 23(3):585-591.
101. Chan D.L., Rozanski E.A., Freeman L.M. Relationship among plasma amino acids, C-reactive protein, illness severity, and outcome in critically ill dogs. J Vet Intern Med 2009, 23(3):559-563.
102. Gebhardt C., Hirschberger J., Rau S., et al. Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care (San Antonio) 2009, 19(5):450-458.
103. Koster L.S., Van S.M., Goddard A., et al. C-reactive protein in canine babesiosis caused by Babesia rossi and its association with outcome. J S Afr Vet Assoc 2009, 80(2):87-91.
104. Kjelgaard-Hansen M., Strom H., Mikkelsen L.F., et al. Grading of surgical trauma by means of canine C-reactive protein measurements. Vet Clin Pathol 2008, 37(s1):6.
105. Otabe K., Ito T., Sugimoto T., et al. C-reactive protein (CRP) measurement in canine serum following experimentally-induced acute gastric mucosal injury. Lab Anim 2000, 34:434-438.
106. Ndung'u J.M., Eckersall P.D., Jennings F.W. Elevation of the concentration of acute phase proteins in dogs infected with Trypanosoma brucei. Acta Trop 1991, 49(2):77-86.
107. Kjelgaard-Hansen M., Jensen A.L., Houser G.A., et al. Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report. Acta Vet Scand 2006, 48(1):9-12.
108. Yuki M., Hirano T. Use of a combination of prednisolone and rosuvastatin for treatment of a pyogranuloma in a dog. J Am Vet Med Assoc 2010, 236(7):767-769.
109. Jergens A.E., Crandell J., Morrison J.A., et al. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial. J Vet Intern Med 2010, 24:269-277.
110. Serin G., Ulutas P.A. Measurement of serum acute phase proteins to monitor postoperative recovery in anoestrous bitches after ovariohysterectomy. Vet Rec 2010, 166(1):20-22.
111. Allen B.V., Kold S.E. Fibrinogen response to surgical tissue trauma in the horse. Eq Vet J 1988, 20(6):441-443.
112. Dabrowski R., Wawron W., Kostro K. Changes in CRP, SAA and haptoglobin produced in response to ovariohysterectomy in healthy bitches and those with pyometra. Theriogenology 2007, 67(2):321-327.
113. Eurell T.E., Wilson D.A., Baker G.J. The effect of exploratory laparotomy on the serum and peritoneal haptoglobin concentrations of the pony. Can J Vet Res 1993, 57:42-44.
114. Miller M.S., Moritz A., Röcken M., et al. Bestimmung von Serum-Amyloid A, Haptoglobin und Fibrinogen als Entzündungsparameter nach Kastration von Hengsten [Evaluation of serum amyloid A, haptoglobin and Fibrinogen as inflammatory markers after castration of stallions]. Tierärztl Prax 2007, 35(G):69-74.
115. Nunokawa Y., Fujinaga T., Taira T., et al. Evaluation of serum amyloid A protein as an acute-phase reactive protein in horses. J Vet Med Sci 1993, 55(6):1011-1016.
116. Pollock P.J., Prendergast M., Schumacher J., et al. Effects of surgery on the acute phase response in clinically normal and diseased horses. Vet Rec 2005, 156:538-542.
117. Dabrowski R., Kostro K., Lisiecka U., et al. Usefulness of C-reactive protein, serum amyloid A component, and haptoglobin determinations in bitches with pyometra for monitoring early post-ovariohysterectomy complications. Theriogenology 2009, 72(4):471-476.
118. Duggan V.E., Holyoak G.R., MacAllister C.G., et al. Influence of induction of parturition on the neonatal acute phase response in foals. Theriogenology 2007, 67:372-381.
119. Paltrinieri S., Giordano A., Villani M., et al. Influence of age and foaling on plasma protein electrophoresis and serum amyloid A and their possible role as markers of neonatal septicaemia. Vet J 2008, 176:393-396.
120. Duggan V.E., Holyoak G.R., MacAllister C.G., et al. Amyloid A in equine colostrum and early milk. Vet Immunol Immunopathol 2008, 121:150-155.
121. Hultén C., Sandgren B., Skioldebrand E., et al. The acute phase protein serum amyloid A (SAA) as an inflammatory marker in equine influenza virus infection. Acta Vet Scand 1999, 40(4):323-333.
122. Crisman M.V., Scarratt W.K., Zimmerman K.L. Blood proteins and inflammation in the horse. Vet Clin North Am Equine Pract 2008, 24(2):285-297.
123. Jacobsen S., Andersen P.H., Toelboell T., et al. Dose dependency and individual variability of the lipopolysaccharide-induced bovine acute phase protein response. J Dairy Sci 2004, 87(10):3330-3339.
124. Heegaard P.M., Klausen J., Nielsen J.P., et al. The porcine acute phase response to infection with Actinobacillus pleuropneumoniae. Haptoglobin, C-reactive protein, major acute phase protein and serum amyloid A protein are sensitive indicators of infection. Comp Biochem Physiol B Biochem Mol Biol 1998, 119(2):365-373.
125. Skovgaard K., Mortensen S., Boye M., et al. Rapid and widely disseminated acute phase protein response after experimental bacterial infection of pigs. Vet Res 2009, 40(3):23.